Literature DB >> 23384712

A man with a DAX1/NR0B1 mutation, normal puberty, and an intact hypothalamic-pituitary-gonadal axis but deteriorating oligospermia during long-term follow-up.

Marie-Laure Raffin-Sanson1, Bérénice Oudet, Sylvie Salenave, Sylvie Brailly-Tabard, Martine Pehuet, Sophie Christin-Maitre, Yves Morel, Jacques Young.   

Abstract

OBJECTIVE: DAX1/NR0B1 mutations cause primary adrenal insufficiency in early childhood and hypogonadotropic hypogonadism (HHG), leading to absent or incomplete sexual maturation. The aim of the study was to prospectively investigate gonadotrope and testicular functions in a patient carrying a DAX1 mutation, who had spontaneous puberty and normal virilization but oligospermia. CASE REPORT: The proband was referred for infertility at the age of 32 years. He reported adrenal insufficiency diagnosed at the age of 19 years. Puberty started at the age of 13 years, with spontaneous virilization, growth spurt, and testicular growth. He reported normal libido and sexual function. Physical examination showed normal virilization, penile length, and testicular volume. However, semen samples showed severe oligospermia. Hormonal measurements confirmed adrenal insufficiency but showed a preserved hypothalamic-pituitary-gonadal axis with normal testosterone and inhibin B; basal and GNRH-stimulated gonadotropin levels and LH pulsatility were also normal. He fathered a first boy by in vitro fertilization and a second boy without medical assistance. As a nephew also had early adrenal insufficiency, the possibility of DAX1 mutation was raised. The same recurrent hemizygous nonsense mutation W39X was found in the proband, his nephew, and in an apparently asymptomatic brother who was found to have adrenal insufficiency, mild HHG, and azoospermia. Several evaluations of the proband over 20 years showed preserved testosterone levels and LH secretion but deteriorating oligospermia.
CONCLUSION: Long-term preservation of normal hypothalamic-pituitary-gonadal function in this patient, contrasting with his severe oligospermia, strongly suggests that DAX1 is required for human spermatogenesis, independently of its known role in gonadotropin secretion.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23384712     DOI: 10.1530/EJE-12-1055

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  11 in total

1.  Case Report: A Novel Truncating Variant of NR0B1 Presented With X-Linked Late-Onset Adrenal Hypoplasia Congenita With Hypogonadotropic Hypogonadism.

Authors:  Feng Zhu; Min Zhou; Xiuling Deng; Yujuan Li; Jing Xiong
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-16       Impact factor: 6.055

2.  Effect of Recombinant Gonadotropin on Testicular Function and Testicular Sperm Extraction in Five Cases of NR0B1 (DAX1) Pathogenic Variants.

Authors:  Jordan Teoli; Vincent Mezzarobba; Lucie Renault; Delphine Mallet; Hervé Lejeune; Pierre Chatelain; Frédérique Tixier; Marc Nicolino; Noël Peretti; Sandrine Giscard D'estaing; Béatrice Cuzin; Frédérique Dijoud; Florence Roucher-Boulez; Ingrid Plotton
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-30       Impact factor: 5.555

3.  A Novel Mutation of DAX-1 Associated with Secretory Azoospermia.

Authors:  Lisha Mou; Nie Xie; Lihua Yang; Yuchen Liu; Ruiying Diao; Zhiming Cai; Honggang Li; Yaoting Gui
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

Review 4.  DAX-1 (NR0B1) and steroidogenic factor-1 (SF-1, NR5A1) in human disease.

Authors:  Jenifer P Suntharalingham; Federica Buonocore; Andrew J Duncan; John C Achermann
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2015-07-14       Impact factor: 4.690

5.  Late-onset X-linked adrenal hypoplasia (DAX-1, NR0B1): two new adult-onset cases from a single center.

Authors:  Nikolaos Kyriakakis; Tolulope Shonibare; Julie Kyaw-Tun; Julie Lynch; Carlos F Lagos; John C Achermann; Robert D Murray
Journal:  Pituitary       Date:  2017-10       Impact factor: 4.107

6.  Identification and Functional Analysis of Six DAX1 Mutations in Patients With X-Linked Adrenal Hypoplasia Congenita.

Authors:  Chanisara Suthiworachai; Rachaneekorn Tammachote; Chalurmpon Srichomthong; Rungnapa Ittiwut; Kanya Suphapeetiporn; Taninee Sahakitrungruang; Vorasuk Shotelersuk
Journal:  J Endocr Soc       Date:  2018-12-12

Review 7.  The evolving role of genetic tests in reproductive medicine.

Authors:  Federica Cariati; Valeria D'Argenio; Rossella Tomaiuolo
Journal:  J Transl Med       Date:  2019-08-14       Impact factor: 5.531

Review 8.  Genetic Evaluation of Patients With Delayed Puberty and Congenital Hypogonadotropic Hypogonadism: Is it Worthy of Consideration?

Authors:  Adalgisa Festa; Giuseppina Rosaria Umano; Emanuele Miraglia Del Giudice; Anna Grandone
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-19       Impact factor: 5.555

9.  Spontaneous fertility and variable spectrum of reproductive phenotype in a family with adult-onset X-linked adrenal insufficiency harboring a novel DAX-1/NR0B1 mutation.

Authors:  Michelle Cerutti C Vargas; Felipe Scipião Moura; Cecília P Elias; Sara R Carvalho; Nelson Rassi; Ilda S Kunii; Magnus R Dias-da-Silva; Flavia Amanda Costa-Barbosa
Journal:  BMC Endocr Disord       Date:  2020-02-06       Impact factor: 2.763

10.  A novel stop mutation (p.(Gln22*)) of DAX1 (NR0B1) results in late-onset X-linked adrenal hypoplasia congenita.

Authors:  Judith Gerards; Michael M Ritter; Elke Kaminsky; Andreas Gal; Wolfgang Hoeppner; Marcus Quinkler
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2017-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.